{"disease":{"id":"coronary-syndrome","name":"coronary syndrome"},"drugs":{"marketed":[{"drug_id":"ticagrelor","indication_name":"Acute coronary syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Brilinta","generic_name":"ticagrelor","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Equilibrative nucleoside transporter 1, P2Y purinoceptor 12, P2Y purinoceptor 12","drug_class":"P2Y12 Platelet Inhibitor [EPC]","quality_score":10,"revenue":"1100","mechanism":null},{"drug_id":"prasugrel","indication_name":"Acute Coronary Syndrome with PCI","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Effient","generic_name":"PRASUGREL","company_name":"Cosette","drug_phase":"marketed","molecular_target":"P2Y purinoceptor 12","drug_class":"P2Y12 Platelet Inhibitor","quality_score":80,"revenue":"400","mechanism":"Effient works by blocking the P2Y12 receptor on platelets, preventing them from aggregating and forming blood clots."},{"drug_id":"prasugrel","indication_name":"Acute coronary syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Effient","generic_name":"PRASUGREL","company_name":"Cosette","drug_phase":"marketed","molecular_target":"P2Y purinoceptor 12","drug_class":"P2Y12 Platelet Inhibitor","quality_score":80,"revenue":"400","mechanism":"Effient works by blocking the P2Y12 receptor on platelets, preventing them from aggregating and forming blood clots."},{"drug_id":"oral-p2y12-receptor-blocker","indication_name":"Prevention of atherothrombotic events in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (MI)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Oral P2Y12 receptor blocker","company_name":"Italian Society of Invasive Cardiology","drug_phase":"marketed","molecular_target":"P2Y12 adenosine diphosphate receptor on platelet surface","drug_class":"Antiplatelet agent; P2Y12 receptor antagonist; Thienopyridine or non-thienopyridine class","quality_score":22,"revenue":null,"mechanism":""},{"drug_id":"verapamil","indication_name":"Acute coronary syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Isoptin","generic_name":"VERAPAMIL","company_name":"","drug_phase":"marketed","molecular_target":"Voltage-dependent L-type calcium channel subunit alpha-1C","drug_class":"Calcium Channel Blocker","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"metoprolol","indication_name":"Acute coronary syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lopressor","generic_name":"metoprolol","company_name":"Generic (originally Ciba-Geigy/Novartis)","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, 5-hydroxytryptamine receptor 1A","drug_class":"Beta-1 selective blocker","quality_score":58,"revenue":null,"mechanism":"Cardioselective beta-1 adrenergic receptor blocker that reduces heart rate, blood pressure, and myocardial oxygen demand."},{"drug_id":"xarelto","indication_name":"Prevention of atherothrombotic events after an acute coronary syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Xarelto","company_name":"University Hospital, Montpellier","drug_phase":"marketed","molecular_target":"Suppressor of tumorigenicity 14 protein, Coagulation factor X, Coagulation factor X","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"tirofiban","indication_name":"Acute coronary syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aggrastat","generic_name":"TIROFIBAN","company_name":"Medicure","drug_phase":"marketed","molecular_target":"Integrin alpha-IIb/beta-3","drug_class":"Platelet Aggregation Inhibitor","quality_score":75,"revenue":null,"mechanism":"Aggrastat works by blocking the integrin alpha-IIb/beta-3 receptor on platelets, preventing them from aggregating and forming blood clots."},{"drug_id":"brilinta","indication_name":"Acute coronary syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Brilinta","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Equilibrative nucleoside transporter 1, P2Y purinoceptor 12, P2Y purinoceptor 12","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"eptifibatide","indication_name":"Acute coronary syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Integrilin","generic_name":"EPTIFIBATIDE","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Integrin alpha-IIb/beta-3","drug_class":"Platelet Aggregation Inhibitor [EPC]","quality_score":75,"revenue":null,"mechanism":"Integrilin blocks the binding of fibrinogen to platelets, preventing them from clumping together and forming clots."},{"drug_id":"integrilin","indication_name":"Acute coronary syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"integrilin","company_name":"University of Cincinnati","drug_phase":"phase_1","molecular_target":"Integrin alpha-IIb/beta-3","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"clopidogrel","indication_name":"Acute coronary syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Plavix","generic_name":"clopidogrel","company_name":"Generic (originally Sanofi/BMS)","drug_phase":"marketed","molecular_target":"Cytochrome P450 2B6, P2Y purinoceptor 12, Sodium-dependent serotonin transporter","drug_class":"Thienopyridine antiplatelet agent","quality_score":55,"revenue":null,"mechanism":"Irreversibly blocks the P2Y12 ADP receptor on platelets, inhibiting platelet aggregation and preventing arterial thrombosis."},{"drug_id":"rivaroxaban","indication_name":"Prevention of atherothrombotic events after an acute coronary syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xarelto","generic_name":"rivaroxaban","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"Factor Xa (FXa)","drug_class":"Direct Factor Xa Inhibitor","quality_score":71,"revenue":null,"mechanism":"Selective FXa inhibitor that decreases thrombin generation without requiring cofactors."}],"pipeline":[],"offLabel":[],"totalMarketed":13,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05198492","title":"Short- and Long-term Health Effects of Air Pollution in Poland","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":8300000,"lead_sponsor_name":"Medical University of Bialystok","has_results":false},{"nct_id":"NCT06255418","title":"Big Data to Assess the Healthcare and Health Outcomes Burden of Acute Coronary Syndromes Complicated With Heart Failure","phase":"","overall_status":"COMPLETED","enrollment_count":7860560,"lead_sponsor_name":"Hospital Universitari de Bellvitge","has_results":false},{"nct_id":"NCT01947959","title":"Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)","phase":"","overall_status":"COMPLETED","enrollment_count":665533,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT03699137","title":"Pre-hospital ECG in Acute Coronary Syndromes","phase":"","overall_status":"COMPLETED","enrollment_count":420048,"lead_sponsor_name":"Kingston University","has_results":false},{"nct_id":"NCT01947985","title":"Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)","phase":"","overall_status":"COMPLETED","enrollment_count":208958,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT03835169","title":"Intra Hospital Mortality Risk Factors in Patients Admitted to Cardiac Intensive Care Units in 2017 in France","phase":"","overall_status":"COMPLETED","enrollment_count":200000,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT05050877","title":"Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention II","phase":"","overall_status":"COMPLETED","enrollment_count":184855,"lead_sponsor_name":"Guangdong Provincial People's Hospital","has_results":false},{"nct_id":"NCT04541498","title":"Impact of Air Pollution and Climate Changes on the Epidemiology of Cardiovascular Disease","phase":"","overall_status":"COMPLETED","enrollment_count":150000,"lead_sponsor_name":"Medical University of Bialystok","has_results":false},{"nct_id":"NCT04008173","title":"The International Survey of Acute Coronary Syndromes-ARCHIVES","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":130000,"lead_sponsor_name":"University of Bologna","has_results":false},{"nct_id":"NCT03823547","title":"Future Optimal Research and Care Evaluation","phase":"","overall_status":"RECRUITING","enrollment_count":99999,"lead_sponsor_name":"J.M. ten Berg","has_results":false},{"nct_id":"NCT02468102","title":"Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)","phase":"","overall_status":"COMPLETED","enrollment_count":99999,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT06512493","title":"South East (Zuid Oost) Netherlands Heart Registry","phase":"","overall_status":"RECRUITING","enrollment_count":99999,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT04407936","title":"Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention","phase":"","overall_status":"COMPLETED","enrollment_count":88938,"lead_sponsor_name":"Guangdong Provincial People's Hospital","has_results":false},{"nct_id":"NCT04597489","title":"Fractional FLOw Reserve In Cardiovascular DiseAses","phase":"","overall_status":"COMPLETED","enrollment_count":64045,"lead_sponsor_name":"LinkCare GmbH","has_results":false},{"nct_id":"NCT01947998","title":"Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)","phase":"","overall_status":"COMPLETED","enrollment_count":50299,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT01852123","title":"High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":48282,"lead_sponsor_name":"University of Edinburgh","has_results":false},{"nct_id":"NCT07428382","title":"Development and Validation of Care Pathway Quality Indicators for Stroke and Chronic Coronary Syndrome Using French Administrative Healthcare Database (DELIQUA-CNV)","phase":"","overall_status":"COMPLETED","enrollment_count":36250,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT01218776","title":"International Survey of Acute Coronary Syndromes","phase":"","overall_status":"RECRUITING","enrollment_count":36000,"lead_sponsor_name":"University of Bologna","has_results":false},{"nct_id":"NCT06881901","title":"Antiplatelet Strategy for CCS Patients Undergoing CABG","phase":"","overall_status":"COMPLETED","enrollment_count":29898,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT05086081","title":"Replication of the ISAR-REACT 5 Antiplatelet Trial in Healthcare Claims Data","phase":"","overall_status":"COMPLETED","enrollment_count":28389,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT05748691","title":"Switching From Cardiac Troponin I to T","phase":"","overall_status":"COMPLETED","enrollment_count":26000,"lead_sponsor_name":"University of Edinburgh","has_results":false},{"nct_id":"NCT05164601","title":"Prognosis of Treated Acute Coronary Syndrome Patients: a Multicenter Study","phase":"","overall_status":"COMPLETED","enrollment_count":22500,"lead_sponsor_name":"Xiang Xie","has_results":false},{"nct_id":"NCT04861363","title":"Follow up of Ticagrelor Treatment Patterns in Chinese Acute Coronary Syndromes Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":20000,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT03473223","title":"Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":18226,"lead_sponsor_name":"CSL Behring","has_results":true},{"nct_id":"NCT03364387","title":"Myocardial Infarction With Non-obstructive Coronary Arteries in Turkish Population","phase":"","overall_status":"COMPLETED","enrollment_count":16026,"lead_sponsor_name":"Cardiovascular Academy Society, Turkey","has_results":false},{"nct_id":"NCT03421873","title":"Effectiveness and Safety of a Clinical Assessment and 0h/1h Troponin Rule-Out Protocol","phase":"","overall_status":"COMPLETED","enrollment_count":16000,"lead_sponsor_name":"Ulf Ekelund","has_results":false},{"nct_id":"NCT05183178","title":"Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":16000,"lead_sponsor_name":"Vastra Gotaland Region","has_results":false},{"nct_id":"NCT06565793","title":"A MAajor RAdiation-based PCI Study in STEMI and NSTEMI","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":15630,"lead_sponsor_name":"Centre Cardiologique du Nord","has_results":false},{"nct_id":"NCT01609842","title":"Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence","phase":"NA","overall_status":"COMPLETED","enrollment_count":14573,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT05754957","title":"A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":14194,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT06197724","title":"MCG for Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients","phase":"","overall_status":"RECRUITING","enrollment_count":14090,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false},{"nct_id":"NCT03286179","title":"Standardizing Emergency Work-ups Around Risk Data","phase":"","overall_status":"COMPLETED","enrollment_count":13419,"lead_sponsor_name":"Kaiser Permanente","has_results":false},{"nct_id":"NCT01000727","title":"The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":13026,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06265714","title":"The IndONEsia ICCU Registry: a Multicenter Cohort of Intensive Cardiovascular Care Units Patients in Indonesia","phase":"","overall_status":"COMPLETED","enrollment_count":12950,"lead_sponsor_name":"Indonesia University","has_results":false},{"nct_id":"NCT06821711","title":"Optimal LDL-C Target in High-risk Patients After PCI","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT02406677","title":"Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":11001,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT03883711","title":"Acute Myocardial Infarction: Prognostic and Therapeutic Evaluation","phase":"","overall_status":"RECRUITING","enrollment_count":11000,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT04895176","title":"incidenCe and predictOrs of heaRt fAiLure After Acute coronarY Syndrome: CORALYS","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"A.O.U. Città della Salute e della Scienza","has_results":false},{"nct_id":"NCT05719545","title":"A Cohort of Patients Undergoing Percutaneous Coronary Intervention","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Su Guohai","has_results":false},{"nct_id":"NCT04044066","title":"Biomarker-based Prognostic Assessment","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false},{"nct_id":"NCT06567418","title":"Retrospective Analysis of the Effect of In-hospital Initiation of PCSK9i on Clinical Outcomes in Chinese ACS Patients","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Yun Dai Chen","has_results":false},{"nct_id":"NCT07515807","title":"Qatar Cardiometabolic Retrospective Cohort-Analysis Using Artificial Intelligence","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Weill Cornell Medical College in Qatar","has_results":false},{"nct_id":"NCT07096973","title":"Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Hochgebirgsklinik Davos","has_results":false},{"nct_id":"NCT04122573","title":"Prospective Multicenter Study for Early Evaluation of Acute Chest Pain","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT05037058","title":"China Diabetes Cardiovascular Initiative","phase":"","overall_status":"UNKNOWN","enrollment_count":9600,"lead_sponsor_name":"Beijing Institute of Heart, Lung and Blood Vessel Diseases","has_results":false},{"nct_id":"NCT00089895","title":"EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":9406,"lead_sponsor_name":"Organon and Co","has_results":true},{"nct_id":"NCT04539925","title":"Air Pollution Exposure on Acute Coronary Syndrome in Two Cohorts of Industrial and Non-industrial Areas","phase":"","overall_status":"COMPLETED","enrollment_count":9046,"lead_sponsor_name":"Medical University of Silesia","has_results":false},{"nct_id":"NCT03239067","title":"Comparison Of Efficacy and Safety Between Ticagrelor and Clopidogrel In Chinese","phase":"","overall_status":"COMPLETED","enrollment_count":9040,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT04624854","title":"Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":8250,"lead_sponsor_name":"Harbin Medical University","has_results":false},{"nct_id":"NCT03664388","title":"Registry of Acute Coronary Syndrome From University Hospital of Vigo","phase":"","overall_status":"UNKNOWN","enrollment_count":8000,"lead_sponsor_name":"Hospital Álvaro Cunqueiro","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}